DK2637704T3 - Radioaktivt mærket phenylimidazol-baserede ligander - Google Patents

Radioaktivt mærket phenylimidazol-baserede ligander

Info

Publication number
DK2637704T3
DK2637704T3 DK11791424.2T DK11791424T DK2637704T3 DK 2637704 T3 DK2637704 T3 DK 2637704T3 DK 11791424 T DK11791424 T DK 11791424T DK 2637704 T3 DK2637704 T3 DK 2637704T3
Authority
DK
Denmark
Prior art keywords
radioactivally
phenylimidazole
labeled
based ligands
ligands
Prior art date
Application number
DK11791424.2T
Other languages
English (en)
Other versions
DK2637704T5 (da
Inventor
Jan Kehler
Benny Bang-Andersen
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of DK2637704T3 publication Critical patent/DK2637704T3/da
Application granted granted Critical
Publication of DK2637704T5 publication Critical patent/DK2637704T5/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0455—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/002—Heterocyclic compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/60—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances involving radioactive labelled substances

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Optics & Photonics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
DK11791424.2T 2010-11-10 2011-11-10 Radioaktivt mærket phenylimidazol-baserede ligander DK2637704T5 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US41193410P 2010-11-10 2010-11-10
DKPA201001023 2010-11-10
PCT/DK2011/000132 WO2012062319A1 (en) 2010-11-10 2011-11-10 Radiolabelled phenylimidazole-based ligands

Publications (2)

Publication Number Publication Date
DK2637704T3 true DK2637704T3 (da) 2015-06-22
DK2637704T5 DK2637704T5 (da) 2015-09-21

Family

ID=45098760

Family Applications (1)

Application Number Title Priority Date Filing Date
DK11791424.2T DK2637704T5 (da) 2010-11-10 2011-11-10 Radioaktivt mærket phenylimidazol-baserede ligander

Country Status (18)

Country Link
US (1) US8592449B1 (da)
EP (1) EP2637704B9 (da)
JP (1) JP5820887B2 (da)
CN (1) CN103732260B (da)
AU (1) AU2011328598B2 (da)
CA (1) CA2817385A1 (da)
DK (1) DK2637704T5 (da)
ES (1) ES2539464T3 (da)
HR (1) HRP20150560T2 (da)
HU (1) HUE025511T2 (da)
ME (1) ME02145B (da)
PL (1) PL2637704T4 (da)
PT (1) PT2637704E (da)
RS (1) RS54039B1 (da)
SG (1) SG190686A1 (da)
SI (1) SI2637704T1 (da)
SM (1) SMT201500139B (da)
WO (1) WO2012062319A1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9790203B2 (en) 2012-11-26 2017-10-17 Abbvie Inc. Inhibitor compounds of phosphodiesterase type 10A
US20150313884A1 (en) 2013-01-15 2015-11-05 Novartis Ag Use of alpha 7 nicotinic acetylcholine receptor agonists
EP2945633B1 (en) * 2013-01-15 2021-06-30 Novartis AG Use of alpha 7 nicotinic acetylcholine receptor agonists
BR112015017674A2 (pt) * 2013-01-31 2017-07-11 Hoffmann La Roche compostos rádio marcados
TW202031250A (zh) 2018-11-06 2020-09-01 丹麥商Ｈ 朗德貝克公司 用於治療負性症狀和認知損傷之pde10a抑制劑

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0425548D0 (en) 2004-11-19 2004-12-22 Glaxo Group Ltd Radiolabelled ligands
ATE521591T1 (de) 2005-01-13 2011-09-15 Ge Healthcare Ltd 11c-markierte benzyl-lactam-verbindungen und deren verwendung als bildgebungsmittel
WO2008020302A2 (en) 2006-08-17 2008-02-21 Pfizer Products Inc. Heteroaromatic quinoline-based compounds as phosphodiesterase (pde) inhibitors
EP2036578A1 (en) 2007-09-13 2009-03-18 Bayer Schering Pharma Aktiengesellschaft Diagnostic agents for positron emission imaging using F-18 radio labeled amino-alcohols
TWI501965B (zh) * 2008-06-20 2015-10-01 Lundbeck & Co As H 作為ｐｄｅ１０ａ酵素抑制劑之新穎苯基咪唑衍生物
WO2010097367A1 (en) 2009-02-24 2010-09-02 Janssen Pharmaceutica Nv Radiolabelled pde10 ligands

Also Published As

Publication number Publication date
JP5820887B2 (ja) 2015-11-24
EP2637704A1 (en) 2013-09-18
HRP20150560T2 (hr) 2015-11-20
RS54039B1 (sr) 2015-10-30
EP2637704B1 (en) 2015-03-25
CN103732260B (zh) 2018-08-10
SMT201500139B (it) 2015-09-07
ES2539464T3 (es) 2015-07-01
ME02145B (me) 2015-10-20
HRP20150560T1 (xx) 2015-07-03
PL2637704T3 (pl) 2015-08-31
US8592449B1 (en) 2013-11-26
EP2637704B9 (en) 2015-08-05
CA2817385A1 (en) 2012-05-18
WO2012062319A1 (en) 2012-05-18
HK1189498A1 (en) 2014-06-13
SG190686A1 (en) 2013-07-31
CN103732260A (zh) 2014-04-16
AU2011328598B2 (en) 2016-04-21
JP2013543851A (ja) 2013-12-09
PL2637704T4 (pl) 2015-08-31
US20130303770A1 (en) 2013-11-14
DK2637704T5 (da) 2015-09-21
AU2011328598A1 (en) 2013-05-30
HUE025511T2 (en) 2016-04-28
SI2637704T1 (sl) 2015-07-31
PT2637704E (pt) 2015-07-21

Similar Documents

Publication Publication Date Title
PL2536745T3 (pl) Nowe immunoadhezyny CTLA4-IG
EP2568873A4 (en) VACUUM RETRACTOR
EP2622917A4 (en) POSITIONING
EP2608687A4 (en) BRA
CO6791565A2 (es) Anticuerpos anti-notch1
EP2623153A4 (en) INTERCONNECTS
DE102011117046A8 (de) Doppelkupplungswindungsgetriebe
EP2660110A4 (en) Wiper blade
DE112011102080A5 (de) Kupplungszentralausrücker
EP2584243A4 (en) INTERCONNECTS
EP2535065A4 (en) DIALYSIS MACHINE
DE102011002623A8 (de) Ventilsteuerzeitversteller
EP2441726A4 (en) LIFT
EP2571003A4 (en) RISK CALCULATION APPARATUS
EP2558859A4 (en) MICRO ARRAYS
EP2633219A4 (en) INTERCONNECTS
SMT201400194B (it) Complesso di flurano
DE112011102089A5 (de) Pumpenanordnung
FI20106246L (fi) Liitosjärjestely
FI20106247L (fi) Pumppu
ES1072929Y (es) Enfardadora
EP2563774A4 (en) Pyrimidinyl indole compounds
FI20100114A0 (fi) Heinäautomaatti
PL393356A1 (pl) Agregat pompowy
FI20105994A0 (fi) Kuormaaja